You are here

OARSI Weekly Briefing - December 3, 2021

Welcome to the OARSI Weekly Briefing - the single resource you need to stay up to date with OARSI & World Congress news, membership announcements, and happenings within the OARSI & OA community.

Bookmark this page for weekly updates.

Join the conversation online by following OARSI on Facebook, LinkedIn, and Twitter.


December 3, 2021 Briefing-at-a-Glance
OARSI Live | DG Webinar | Member Spotlight | Fraudulent Conferences | Become a Sponsor, Supporter, or Exhibitor | Important Dates | Weekly Briefing Archive

OARSI Live is Back! Wednesday, December 15 at 9:00 am ET

By popular demand, the OARSI Live webinar series returns this month. The OARSI Engagement Committee has created an exciting program of monthly presentations, including keynote speakers, journal clubs, and OARSI Discussion Group forums. OARSI Live webinars will typically be scheduled on the third Wednesday of each month and are offered free for OARSI members. Session recordings will be made available on the OARSI website.

The next OARSI Live will be held on Wednesday, December 15 at 9:00 am ET. Tonia Vincent, MD, PhD, will present The importance and implications of mechanoflammation in the pathogenesis of OA. Dr. Vincent is a Consultant Rheumatologist and Professor of Musculoskeletal Biology at the University of Oxford, where she directs the Centre for OA Pathogenesis.

To register and for more information, please click HERE


Webinar: Consensus Methods: The Past, Present, and Maybe the Future

The OARSI OA Prevention Related to Sports, Exercise, and Physical Activity Discussion Group is hosting a webinar on Thursday, December 9 at 3:00 pm ET. During this webinar, the three presenters will:

Address the current recommended best evidence and procedures for consensus.
Discuss direct experience with various consensus approaches.
Tips and tricks for undertaking a consensus project; and insights into the future of this field.

To register and for more information, please click HERE

OARSI Request for Endorsement or Sponsorship Opportunities

The OARSI Strategic Alliance Committee fosters relationships with societies, foundations, groups and industry partners with an interest in OA and related research to advance knowledge in this area. OARSI members and societies with an interest in OA are welcome and encouraged to submit an Endorsement/Sponsorship/Initiative Request Form for consideration.

If you have any questions about the endorsement/sponsorship process, please contact OARSI Executive Director, Elizabeth Grotos at

Breakthrough Research

Prof. Dr. Wiltrud Richter and fellow researchers are excited about a major breakthrough in the steering of mesenchymal stroma cells (MSC) into the chondral lineage in vivo by mimicking the heparan sulfate structures of the stem cell niche. Read more…

Member Spotlight: Chang-Hai Ding

This week's OARSI Member Spotlight is Board of Directors Member at Large, Chang-Hai Ding.

How long have you been a member of OARSI and why did you join?

I have been a member of OARSI since 2007

What do you enjoy most about OARSI?

I enjoy reading the official journal of OARSI, Osteoarthritis and Cartilage, and have learned a lot about osteoarthritis and applied the knowledge and methods in my own research; I enjoy attending OARSl  World Congress every year. In the meeting, I can meet older friends and know some new friends and know some new advances in the OA area. I enjoy the friendly environment as a member and a board member of OARSI.

Tell us a little bit about your research?

I have performed epidemiological and clinical research in OA. We reported that vitamin D deficiency, inflammatory and metabolic factors, and infrapatellar fat pad could play roles in the pathogenesis of knee OA. Vitamin D supplementation had no significant effects on cartilage volume loss and WOMAC pain in knee OA patients with insufficient vitamin D but could have effects on WOMAC function, VAS knee pain, effusion-synovitis, depression, and foot pain. Currently, I am performing several precision clinical trials to examine if treatments such as methotrexate and metformin have therapeutic effects on a specific phenotype of knee OA. In addition, I have started to do some experimental studies to determine the roles of non-coding RNA, metabolomics, and the local immune microenvironment in OA animal models and in vitro.

What are you most excited about for OARSI in 2022?

What I am most excited about for OARSI in 2022 is OARSI World Congress which will be held in Berlin in April. We did not come together for 2 years due to COVID-19 and I am looking forward to seeing the old and new friends in Berlin.

What do you enjoy doing in your free time?

In my free time, I enjoy playing tennis with friends. I also enjoy playing cards with my students and staff.

Beware of Fraudulent Conferences

We are seeing an increasing number of incidences of fake societies claiming to be looking for studies to include in journals and promoting fraudulent conferences.  Individuals can be deceived into thinking that they are paying to register for a conference that doesn't exist. Many of the bogus conferences are related to osteoarthritis. 

Some telltale signs to watch out for include email messages that include excessive use of punctuation, awkward language (including the words greetings, groovy and excellent in the first sentence) and a questionable reply to email address.  Please be mindful and cautious of responding to requests from organizations that are unfamiliar to you.

Contact Dana Groves
Manager of Relations Manager
Download Our 2022 Sponsorship, Support & Exhibit Prospectus

Important Dates & Upcoming Deadlines

  • December 9, 2021 - SEPA Webinar

  • December 15, 2021 - OARSI Live

  • April 7 - 10, 2022 - OARSI World Congress in Berlin, Germany

2022 Sponsors & Exhibits

2022 Industry Partners

Past OARSI Weekly Briefings

Featured Resources

OARSI White Paper- OA as a Serious Disease

By Various

Patient Summary- Non Surgical Treatment of Knee Osteoarthritis

By Multiple Authors